Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Chemical and Ribosomal Synthesis of Topologically Controlled Bicyclic and Tricyclic Peptide Scaffolds Primed by Selenoether Formation.

Biocompatible and Selective Generation of Bicyclic Peptides

Chemoenzymatic tandem cyclization for the facile synthesis of bicyclic peptides

Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization

Constructing Cyclic Peptides Using an On-Tether Sulfonium Center

Efficient synthesis of bisulfide-bridged bicyclopeptides by intramolecular photoinduced electron transfer cycloreaction

Total Liquid-phase Sythesis, Head-to-tail Cyclization and Synergistic Self-cleavage of Peptide on Small-molecular Supports

Diaminodiacid-based solid-phase synthesis of peptide disulfide bond mimics.

Triscysteine disulfide-directing motifs enabling design and discovery of multicyclic peptide binders

Peptide Macrocycles Developed from Precisely Regulated Multiple Cyclization of Unprotected Peptides

Efficient Enzymatic Cyclization of Disulfide-Rich Peptides by Using Peptide Ligases

Cover Feature: Ordered and Isomerically Stable Bicyclic Peptide Scaffolds Constrained Through Cystine Bridges and Proline Turns (chembiochem 12/2019)

Head-to-tail Cyclization for the Synthesis of Naturally Occurring Cyclic Peptides on Organophosphorus Small-Molecular Supports

Artificial disulfide-rich peptide scaffolds with precisely defined disulfide patterns and a minimized number of isomers.

Design and Synthesis of Cross-Link-Dense Peptides by Manipulating Regioselective Bisthioether Cross-Linking and Orthogonal Disulfide Pairing

Design and Ribosomal Incorporation of Noncanonical Disulfide-Directing Motifs for the Development of Multicyclic Peptide Libraries.

De Novo Design of Constrained and Sequence-Independent Peptide Scaffolds with Topologically-Formidable Disulfide Connectivities

Chemical Synthesis of a Cyclotide Via Intramolecular Cyclization of Peptide O-esters

Biosynthetic Strategies for Macrocyclic Peptides

- rich peptide sca ff olds with precisely de fi ned disul fi de patterns and a minimized number of isomers †

Precisely Regulated and Efficient Locking of Linear Peptides into Stable Multicyclic Topologies through a One-Pot Reaction.